Copper-64 Radiopharmaceuticals : Production, Quality Control and Clinical Applications / International Atomic Energy Agency.

Format:

Book

Author/Creator:

International Atomic Energy Agency, author, issuing body.

Series:

IAEA radioisotopes and radiopharmaceuticals series ; Volume 7.

IAEA Radioisotopes and Radiopharmaceuticals Series No Series ; Volume 7

Language:

English

Subjects (All):

Radiopharmaceuticals.

Copper--Isotopes.

Copper.

Tomography, Emission.

Physical Description:

1 online resource (140 pages)

Edition:

First edition.

Place of Publication:

Vienna, Austria : International Atomic Energy Agency, [2022]

Summary:

Positron emission tomography (PET) is an important clinical tool, and with its longer half-life, copper-64 has several unique attributes that make it a multi-purpose radionuclide with many potential applications. Additionally, copper as a trace element plays a pivotal role in several human metabolic and pathologic diseases and is involved in malignant cells biochemistry pathways. This offers the opportunity for scientists to explore the theranostic capabilities of copper-64. This current publication, arising from an IAEA Coordinated Research Project, describes the biochemical and radiopharmaceutical aspects of copper-64, and its clinical applications, with specific guidelines and methods for the production of copper-64 chloride, peptide and monoclonal antibody radiopharmaceuticals. It is expected to be of use to all professionals involved in the field by specifying ideal production, formulation and quality control methods.

Notes:

Description based on publisher supplied metadata and other sources.

Description based on print version record.

Other Format:

Print version: IAEA Copper-64 Radiopharmaceuticals: Production, Quality Control and Clinical Applications

ISBN:

9789201293213